ALERT: 1 Week Before Aurora Cannabis (TSX:ACB) Earnings

Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB) is set to release earnings next week, as its stock nears a 52-week low.

| More on:
edit Businessman using calculator next to laptop

Image source: Getty Images.

We are a few weeks removed from the next stage of cannabis legalization. Cannabis 2.0 will introduce products like vape pens and edibles into the legal market. Aurora Cannabis (TSX:ACB)(NYSE:ACB), one of the top producers in the world, has seen its stock fall 15.7% month over month. According to Aurora’s upcoming events on its main site, the company is set to release its first-quarter fiscal 2020 results after markets close on November 14.

Late last month, I’d discussed Aurora’s value ahead of its earnings release. Shares were close to its 52-week low of $4.59 at the time of this writing.

What to expect from Q1 earnings

Analysts are expecting a big bump in revenue in the first quarter. Unfortunately, the broader sector is still struggling, as we have passed the one-year anniversary of recreational legalization. Inventories are on the rise, but a shortage in legal brick-and-mortar cannabis stores has put pressure on producers. Aurora CEO Terry Booth specifically cited his disappointment with Ontario and B.C.’s rollout in recent months, reserving some praise for Alberta’s handling of legalization.

In its fourth-quarter fiscal 2019 report, Aurora’s net revenue fell short of expectations. Other top producers faced similar challenges. Canopy Growth appeared to be on track for $1 billion in sales in fiscal 2020, but its first-quarter report disappointed. The company went on to project that it will reach profitability in the next three to five years, which sparked a sell-off in the stock.

Aurora has a large product lineup set for launch in December. Edibles have emerged as the preferred method of consumption for many users. These products have only been available through the black market over the past several years. Aurora chief corporate officer Cam Battley said that legalization “will give the legal industry the real opportunity to make significant strides in replacing black market sales.”

The company has set up production hubs in Eastern and Western Canada that will help its roll out of gummies, baked goods, mints, and chocolates in the edible category. It plans to offer vape products that will target all major consumer segments. The ongoing controversy around e-cigarettes is not expected to have a significant impact on the sale of vape pens in the near term.

Edibles are not set to make a huge impact early in the roll out, but Aurora anticipates that their sale will improve gross margins and adjusted EBITDA. Aurora had hoped to achieve profitability in late fiscal 2019, but it has been forced to push back forecasts. The company now expect positive EBITDA by the second quarter of fiscal 2020, but this is still dependent on a broader retail rollout.

Should you buy Aurora today?

Aurora stock looks tempting at current price levels. The cannabis sector has been pummeled in 2019, and there is a lot of uncertainty as we look ahead to the new year. Shares have retreated to fair value, and there is still high-growth potential in this evolving industry. I’m still looking to stack Aurora stock ahead of earnings.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ambrose O'Callaghan has no position in any of the stocks mentioned.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »